---
figid: PMC6593470__PROS-79-937-g005
figlink: /pmc/articles/PMC6593470/figure/pros23799-fig-0005/
number: Figure 5
caption: Schematic representation of alternative mechanisms of CRPC. Simplified overview
  of the classical androgen synthesis pathway. Thick arrows indicate the preferred
  steps in human androgen biosynthesis and subsequent AR activation as reported in
  the literature. Abiraterone and TAK700 effectively inhibit steroid synthesis, but
  cannot prevent direct binding of the steroid precursors Preg or Prog to the AR (dotted
  line). Direct AR‐antagonism by enzalutamide will still block activation by either
  DHT or Prog. AR, androgen receptor; CRPC, castration‐resistant prostate cancer;
  CYP17A1, cytochrome P450, family 17, subfamily A, polypeptide 1; DHT, dihydrotestosterone;
  Preg, pregnenolone; Prog, progesterone
pmcid: PMC6593470
papertitle: 'A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating
  CYP17A1 substrates activate androgen receptor signaling.'
reftext: Jan M. Moll, et al. Prostate. 2019 Jun 15;79(9):937-948.
pmc_ranked_result_index: '8516'
pathway_score: 0.8983546
filename: PROS-79-937-g005.jpg
figtitle: Schematic representation of alternative mechanisms of CRPC
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6593470__PROS-79-937-g005.html
  '@type': Dataset
  description: Schematic representation of alternative mechanisms of CRPC. Simplified
    overview of the classical androgen synthesis pathway. Thick arrows indicate the
    preferred steps in human androgen biosynthesis and subsequent AR activation as
    reported in the literature. Abiraterone and TAK700 effectively inhibit steroid
    synthesis, but cannot prevent direct binding of the steroid precursors Preg or
    Prog to the AR (dotted line). Direct AR‐antagonism by enzalutamide will still
    block activation by either DHT or Prog. AR, androgen receptor; CRPC, castration‐resistant
    prostate cancer; CYP17A1, cytochrome P450, family 17, subfamily A, polypeptide
    1; DHT, dihydrotestosterone; Preg, pregnenolone; Prog, progesterone
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSD3B1
  - CYP17A1
  - Cholesterol
  - Pregnenolone
  - 17aOH-Pregnenolone
  - DHEA
  - 5-Androstenediol
  - Progesterone
  - OH-Progesterone
  - Androstenedione
  - Testosterone
  - Androstanedione
  - Abiraterone
  - Enzalutamide
  - Androgen
  - T877A
genes:
- word: HSD3B1,2
  symbol: HSD3B1
  source: hgnc_symbol
  hgnc_symbol: HSD3B1
  entrez: '3283'
- word: CYP17A1
  symbol: CYP17A1
  source: hgnc_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
chemicals:
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Pregnenolone
  source: MESH
  identifier: D011284
- word: 17aOH-Pregnenolone
  source: MESH
  identifier: D011284
- word: DHEA
  source: MESH
  identifier: D003687
- word: 5-Androstenediol
  source: MESH
  identifier: D015114
- word: Progesterone
  source: MESH
  identifier: D011374
- word: OH-Progesterone
  source: MESH
  identifier: D011374
- word: Androstenedione
  source: MESH
  identifier: D000735
- word: Testosterone
  source: MESH
  identifier: D013739
- word: Androstanedione
  source: MESH
  identifier: C006576
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: Enzalutamide
  source: MESH
  identifier: C540278
- word: Androgen
  source: MESH
  identifier: D000728
- word: T877A
  source: MESH
  identifier: C049347
diseases: []
---
